US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Lineage

41.28

+0.56501.39%

Volume:203.66K

Turnover:8.34M

Market Cap:9.44B

PE:-15.59

High:41.28

Open:40.73

Low:40.41

Close:40.71

52wk High:86.03

52wk Low:38.83

Shares:228.77M

Float Shares:57.64M

Volume Ratio:0.35

T/O Rate:0.35%

Dividend:1.96

Dividend Rate:4.75%

EPS(TTM):-2.6473

EPS(LYR):-3.6963

ROE:-8.17%

ROA:0.36%

PB:1.09

PE(LYR):-11.17

Loading ...

Overview Company News Filings

Lineage Cell Therapeutics Is Maintained at Buy by D. Boral Capital

Strategic Partnerships and Promising Trial Results Bolster Buy Rating for Lineage Cell Therapeutics

Lineage Therap Partners with WDI for Hearing Loss Research

Capybobo's Tokyo Debut, PYBOBO Limited Skin Outfit Highly Praised

Lineage Inc. Faces Class Action Lawsuit Over Securities Fraud Allegations Following IPO

Lineage Is Maintained at Buy by Truist Securities

Truist Cuts Price Target on Lineage to $53 From $60, Keeps Buy Rating

MT Newswires Live

Lineage price target lowered to $53 from $60 at Truist

BRIEF-Lineage, Port of New Orleans Collaborate To Expand Bonded Warehouse Space

Lineage Inc. Expands Global Trade Capabilities with New Customs Bonded Warehouse in New Orleans

Lineage and Port of New Orleans Collaborate to Expand Bonded Warehouse Space, Strengthening Global Trade Flows

THOMSON REUTERS

Evercore ISI Remains a Hold on Lineage, Inc. (LINE)

Kevin Patrick Marchetti, Co-Executive Chairman, Reports Acquisition of Lineage Inc. Common Shares

Capybobo debuts at WebX 2025, unveiling Web3-native Collectible NFT Apparel IP.

Lineage Is Maintained at Outperform by RBC Capital

RBC Cuts Price Target on Lineage to $51 From $64, Keeps Outperform Rating

MT Newswires Live

RBC Capital Sticks to Its Buy Rating for Lineage, Inc. (LINE)

Promising Developments and Strong Financial Position Support Buy Rating for Lineage Cell Therapeutics

Lineage Cell Therapeutics Reports Q2 2025 Progress and Challenges

Lineage Cell Revenue Doubles in Q2

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/LINE/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LINE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LINE\",,,,,undefined,":{"symbol":"LINE","market":"US","secType":"STK","nameCN":"Lineage","latestPrice":41.275,"timestamp":1756312864740,"preClose":40.71,"halted":0,"volume":203661,"delay":0,"floatShares":57642784,"shares":228767627,"eps":-2.647321,"marketStatus":"Trading","change":0.565,"latestTime":"08-27 12:41:10 EDT","open":40.73,"high":41.28,"low":40.41,"amount":8339592.0923999995,"amplitude":0.021371,"askPrice":41.29,"askSize":3,"bidPrice":41.25,"bidSize":300,"shortable":3,"etf":0,"ttmEps":-2.647321,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1756324800000},"marketStatusCode":2,"adr":0,"listingDate":1721880000000,"exchange":"NASDAQ","adjPreClose":40.71,"dividendRate":0.047547,"preHourTrading":{"tag":"盘前","latestPrice":40,"preClose":40.71,"latestTime":"05:11 EDT","volume":2,"amount":81.29,"timestamp":1756285900062},"postHourTrading":{"tag":"盘后","latestPrice":41.52,"preClose":40.71,"latestTime":"17:33 EDT","volume":267008,"amount":10870280.2404,"timestamp":1756244015117},"volumeRatio":0.345548,"impliedVol":0.3343,"impliedVolPercentile":0.224},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LINE\",,,,,undefined,":{"symbol":"LINE","floatShares":57642784,"roa":"0.36%","roe":"-8.17%","lyrEps":-3.696335,"volumeRatio":0.345548,"shares":228767627,"dividePrice":1.9625,"high":41.28,"amplitude":0.021371,"preClose":40.71,"low":40.41,"week52Low":38.83,"pbRate":"1.09","psRate":"1.78","week52High":86.03,"institutionHeld":0.1784,"latestPrice":41.275,"committee":0.980198,"eps":-2.647321,"divideRate":0.047547,"volume":203661,"delay":0,"ttmEps":-2.647321,"open":40.73,"prevYearClose":58.57,"prevWeekClose":40.28,"prevMonthClose":43.15,"prevQuarterClose":43.52,"fiveDayClose":39.18,"twentyDayClose":43.55,"sixtyDayClose":43.02},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LINE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-06","symbol":"LINE","fiscalQuarterEnding":"2025/06","expectedEps":0.62,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"pre","actualEps":0.81},{"date":"2025-06-30","symbol":"LINE","amount":0.5275,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-30","defaultRemindTime":1751290200000,"name":"Lineage","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-21","payableDate":"2025-06-30","currency":"USD","dateTimestamp":1751256000000,"payDate":"2025-07-21"},{"market":"US","date":"2025-04-30","symbol":"LINE","fiscalQuarterEnding":"2025/03","expectedEps":0.67,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1745985600000,"reportTimeType":"pre","actualEps":0.86},{"date":"2025-03-31","symbol":"LINE","amount":0.5275,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-31","defaultRemindTime":1743427800000,"name":"Lineage","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-21","payableDate":"2025-03-31","currency":"USD","dateTimestamp":1743393600000,"payDate":"2025-04-21"},{"market":"US","date":"2025-02-26","symbol":"LINE","fiscalQuarterEnding":"2024/12","expectedEps":0.68,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1740546000000,"reportTimeType":"pre","actualEps":0.83}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LINE\",market:\"US\",,,undefined,":[{"executeDate":"2024-09-30","recordDate":"2024-09-30","paymentDate":"2024-10-21","value":0.38,"currency":"USD"},{"executeDate":"2024-12-31","recordDate":"2024-12-31","paymentDate":"2025-01-21","value":0.5275,"currency":"USD"},{"executeDate":"2025-03-31","recordDate":"2025-03-31","paymentDate":"2025-04-21","value":0.5275,"currency":"USD"},{"executeDate":"2025-06-30","recordDate":"2025-06-30","paymentDate":"2025-07-21","value":0.5275,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LINE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.0526,"buy":0.3158,"hold":0.4737,"sell":0.1579,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.4737,"analysts":19,"updateTime":1754971200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LINE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LINE","date":"2025-08-26","current":-17.002889,"percent":0.737226,"low":-150.19606,"twenty":-88.285736,"median":-20.615045,"eighty":-16.561064,"high":-14.964597,"avg":-42.532414,"sd":40.573514,"marketCap":9555623779},"quantilePoints":[{"date":"2024-07-26","current":-135.297148,"twenty":-133.240266,"median":-129.59991,"eighty":-127.33081,"marketCap":18224525800},{"date":"2024-08-02","current":-145.820923,"twenty":-146.760391,"median":-140.374056,"eighty":-130.053731,"marketCap":19642078377},{"date":"2024-08-09","current":-149.178586,"twenty":-148.252685,"median":-145.575034,"eighty":-133.925893,"marketCap":20094355563},{"date":"2024-08-16","current":-142.403908,"twenty":-146.770565,"median":-143.819892,"eighty":-138.343293,"marketCap":19181806393},{"date":"2024-08-23","current":-98.688122,"twenty":-146.923186,"median":-143.404424,"eighty":-130.053731,"marketCap":19540248095},{"date":"2024-08-30","current":-96.480231,"twenty":-146.227913,"median":-142.463261,"eighty":-98.833015,"marketCap":19103085705},{"date":"2024-09-06","current":-93.156895,"twenty":-146.119382,"median":-140.374056,"eighty":-96.954008,"marketCap":18445065232},{"date":"2024-09-13","current":-95.732768,"twenty":-145.993894,"median":-129.59991,"eighty":-95.649972,"marketCap":18955088021},{"date":"2024-09-20","current":-93.087899,"twenty":-145.732742,"median":-99.424085,"eighty":-94.909408,"marketCap":18431403907},{"date":"2024-09-27","current":-90.02905,"twenty":-145.49194,"median":-98.486882,"eighty":-94.26544,"marketCap":17825751846},{"date":"2024-10-04","current":-88.39613,"twenty":-144.725443,"median":-96.871212,"eighty":-93.115497,"marketCap":17502433828},{"date":"2024-10-11","current":-86.556221,"twenty":-143.487517,"median":-95.865011,"eighty":-90.408531,"marketCap":17138131836},{"date":"2024-10-18","current":-89.178092,"twenty":-142.853292,"median":-95.28429,"eighty":-88.708915,"marketCap":17657262174},{"date":"2024-10-25","current":-87.671666,"twenty":-142.575183,"median":-94.927808,"eighty":-88.455927,"marketCap":17358989918},{"date":"2024-11-01","current":-83.106392,"twenty":-142.43952,"median":-94.755316,"eighty":-88.014349,"marketCap":16455065601},{"date":"2024-11-08","current":-23.853641,"twenty":-141.591967,"median":-94.082599,"eighty":-87.618769,"marketCap":15361744673},{"date":"2024-11-15","current":-22.510722,"twenty":-138.343293,"median":-93.156895,"eighty":-86.629817,"marketCap":14496904918},{"date":"2024-11-22","current":-22.712691,"twenty":-133.925893,"median":-92.24269,"eighty":-85.252186,"marketCap":14626973166},{"date":"2024-11-29","current":-22.471745,"twenty":-130.961371,"median":-90.805262,"eighty":-83.56407,"marketCap":14471804028},{"date":"2024-12-06","current":-22.011114,"twenty":-127.33081,"median":-90.02905,"eighty":-23.887657,"marketCap":14175157147},{"date":"2024-12-13","current":-21.97568,"twenty":-121.749465,"median":-89.580572,"eighty":-23.012456,"marketCap":14152338156},{"date":"2024-12-20","current":-20.753234,"twenty":-99.32519,"median":-88.545623,"eighty":-22.64466,"marketCap":13365082970},{"date":"2024-12-27","current":-20.905597,"twenty":-98.92961,"median":-88.258137,"eighty":-22.510722,"marketCap":13463204631},{"date":"2025-01-03","current":-20.905597,"twenty":-98.73642,"median":-88.20064,"eighty":-22.420722,"marketCap":13463204631},{"date":"2025-01-10","current":-19.654805,"twenty":-98.446634,"median":-87.890155,"eighty":-22.273319,"marketCap":12657694252},{"date":"2025-01-17","current":-20.615045,"twenty":-97.561177,"median":-87.625669,"eighty":-22.140799,"marketCap":13276088905},{"date":"2025-01-24","current":-21.245756,"twenty":-96.995405,"median":-87.407179,"eighty":-21.811979,"marketCap":13682266943},{"date":"2025-01-31","current":-21.259929,"twenty":-96.71482,"median":-86.556221,"eighty":-21.261347,"marketCap":13691394540},{"date":"2025-02-07","current":-20.522919,"twenty":-96.287041,"median":-85.872006,"eighty":-21.229457,"marketCap":13216759529},{"date":"2025-02-14","current":-19.973704,"twenty":-95.89146,"median":-85.084294,"eighty":-20.979298,"marketCap":12863065170},{"date":"2025-02-21","current":-19.091417,"twenty":-95.705169,"median":-83.416877,"eighty":-20.860243,"marketCap":12294872296},{"date":"2025-02-28","current":-20.706163,"twenty":-95.532678,"median":-24.073327,"eighty":-20.758903,"marketCap":13748892325},{"date":"2025-03-07","current":-21.053271,"twenty":-95.272791,"median":-23.651671,"eighty":-20.753234,"marketCap":13979371682},{"date":"2025-03-14","current":-20.118486,"twenty":-95.185395,"median":-23.100685,"eighty":-20.713451,"marketCap":13358674800},{"date":"2025-03-21","current":-20.070372,"twenty":-94.983005,"median":-22.840251,"eighty":-20.684293,"marketCap":13326727167},{"date":"2025-03-28","current":-20.269701,"twenty":-94.831212,"median":-22.58336,"eighty":-20.618588,"marketCap":13459081649},{"date":"2025-04-04","current":-18.678506,"twenty":-94.801314,"median":-22.510722,"eighty":-20.546012,"marketCap":12402527766},{"date":"2025-04-11","current":-18.45512,"twenty":-94.693219,"median":-22.452257,"eighty":-20.399959,"marketCap":12254199467},{"date":"2025-04-17","current":-19.214632,"twenty":-94.444831,"median":-22.33887,"eighty":-20.283448,"marketCap":12758515683},{"date":"2025-04-25","current":-19.194012,"twenty":-94.145846,"median":-22.252059,"eighty":-20.149417,"marketCap":12744823840},{"date":"2025-05-02","current":-16.587441,"twenty":-94.019352,"median":-22.179422,"eighty":-20.037483,"marketCap":10350562942},{"date":"2025-05-09","current":-16.711993,"twenty":-93.904358,"median":-22.011114,"eighty":-19.920554,"marketCap":10428283601},{"date":"2025-05-16","current":-17.448317,"twenty":-93.156895,"median":-21.581486,"eighty":-19.676065,"marketCap":10887749844},{"date":"2025-05-23","current":-16.71932,"twenty":-93.087899,"median":-21.263473,"eighty":-19.558303,"marketCap":10432855404},{"date":"2025-05-30","current":-16.092895,"twenty":-92.811913,"median":-21.249299,"eighty":-19.409177,"marketCap":10041966212},{"date":"2025-06-06","current":-16.096558,"twenty":-91.942555,"median":-21.231583,"eighty":-19.343951,"marketCap":10044252113},{"date":"2025-06-13","current":-16.646053,"twenty":-91.006502,"median":-21.199693,"eighty":-19.183414,"marketCap":10387137370},{"date":"2025-06-20","current":-16.320019,"twenty":-90.801812,"median":-21.08985,"eighty":-19.019731,"marketCap":10183692118},{"date":"2025-06-27","current":-16.429919,"twenty":-90.394732,"median":-20.934756,"eighty":-18.674382,"marketCap":10252269169},{"date":"2025-07-03","current":-15.946362,"twenty":-90.091147,"median":-20.886643,"eighty":-18.14994,"marketCap":9950530143},{"date":"2025-07-11","current":-15.77785,"twenty":-90.01985,"median":-20.860815,"eighty":-17.486415,"marketCap":9845378664},{"date":"2025-07-18","current":-15.191722,"twenty":-89.932455,"median":-20.808156,"eighty":-17.309844,"marketCap":9479634391},{"date":"2025-07-25","current":-15.847453,"twenty":-89.62887,"median":-20.753234,"eighty":-16.815894,"marketCap":9888810797},{"date":"2025-08-01","current":-15.807157,"twenty":-89.274687,"median":-20.746147,"eighty":-16.701003,"marketCap":9863665878},{"date":"2025-08-08","current":-17.422161,"twenty":-88.925104,"median":-20.723347,"eighty":-16.650449,"marketCap":9791254435},{"date":"2025-08-15","current":-16.376017,"twenty":-88.485826,"median":-20.675311,"eighty":-16.612351,"marketCap":9203321634},{"date":"2025-08-22","current":-15.911969,"twenty":-88.340933,"median":-20.632761,"eighty":-16.564012,"marketCap":8942526539},{"date":"2025-08-26","current":-17.002889,"twenty":-88.285736,"median":-20.615045,"eighty":-16.561064,"marketCap":9555623779}],"updateTime":1756291779726},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LINE\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2562462677","title":"Lineage Cell Therapeutics Is Maintained at Buy by D. Boral Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2562462677","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562462677?lang=en_us&edition=fundamental","pubTime":"2025-08-27 20:27","pubTimestamp":1756297620,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LCTX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  August 27, 2025 08:27 ET (12:27 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LINE","LENZ","LCTX"],"gpt_icon":0},{"id":"2562737203","title":"Strategic Partnerships and Promising Trial Results Bolster Buy Rating for Lineage Cell Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2562737203","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562737203?lang=en_us&edition=fundamental","pubTime":"2025-08-26 22:25","pubTimestamp":1756218314,"startTime":"0","endTime":"0","summary":"In a report released today, Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on Lineage Therap, with a price target of $9.00. Joseph P...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/strategic-partnerships-and-promising-trial-results-bolster-buy-rating-for-lineage-cell-therapeutics-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/strategic-partnerships-and-promising-trial-results-bolster-buy-rating-for-lineage-cell-therapeutics-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LINE","LENZ"],"gpt_icon":0},{"id":"2562349577","title":"Lineage Therap Partners with WDI for Hearing Loss Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2562349577","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562349577?lang=en_us&edition=fundamental","pubTime":"2025-08-26 21:29","pubTimestamp":1756214950,"startTime":"0","endTime":"0","summary":"Lineage Therap ( ($LCTX) ) has issued an announcement. Lineage Cell Therapeutics announced a multi-year research collaboration with William Demant ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lineage-therap-partners-with-wdi-for-hearing-loss-research?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lineage-therap-partners-with-wdi-for-hearing-loss-research?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["WDI","BK4224","LINE"],"gpt_icon":0},{"id":"2561949263","title":"Capybobo's Tokyo Debut, PYBOBO Limited Skin Outfit Highly Praised","url":"https://stock-news.laohu8.com/highlight/detail?id=2561949263","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561949263?lang=en_us&edition=fundamental","pubTime":"2025-08-24 20:23","pubTimestamp":1756038180,"startTime":"0","endTime":"0","summary":"BlockBeats News, August 24th, Catizen's global Web3 game Capybobo made its appearance at the Tokyo LINE NEXT & BGW Festa, delivering a keynote speech and sharing its new exploration in integrating gaming with trendy toys and facilitating online-offline interactions.At the event venue, the Capybobo booth showcased a variety of exquisite gifts from the Catizen ecosystem. Among them, the PYBOBO limited skin doll outfit paired with the Labubu figurine became the highlight of the entire event, receiving enthusiastic praise from the audience. Many players successfully obtained this special set at the event, truly experiencing the unique charm of integrating virtual creativity with physical trendy toys, keeping the event atmosphere lively and upbeat.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//en/flash/308966","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_live","symbols":["BK4224","NEXT","LINE","BK4144"],"gpt_icon":0},{"id":"2561402608","title":"Lineage Inc. Faces Class Action Lawsuit Over Securities Fraud Allegations Following IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2561402608","media":"Reuters","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561402608?lang=en_us&edition=fundamental","pubTime":"2025-08-23 02:42","pubTimestamp":1755888132,"startTime":"0","endTime":"0","summary":"Lineage Inc. is facing a class action lawsuit filed by investors alleging securities fraud related to the company's initial public offering on July 26, 2024. The lawsuit is being managed by Levi & Korsinsky, a law firm specializing in securities litigation, and targets all purchasers of Lineage common stock linked to the registration statement used during the IPO. Investors who have experienced financial losses are encouraged to join the class action. Levi & Korsinsky has a strong track record in securing significant settlements for shareholders and is now representing those affected by this case.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lineage Inc. published the original content used to generate this news brief via ACCESS Newsw","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250822:nNDL3SHfgZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LINE","BK4224"],"gpt_icon":0},{"id":"2561472534","title":"Lineage Is Maintained at Buy by Truist Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2561472534","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561472534?lang=en_us&edition=fundamental","pubTime":"2025-08-22 20:57","pubTimestamp":1755867420,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LINE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  August 22, 2025 08:57 ET (12:57 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LINE"],"gpt_icon":0},{"id":"2561476498","title":"Truist Cuts Price Target on Lineage to $53 From $60, Keeps Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2561476498","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561476498?lang=en_us&edition=fundamental","pubTime":"2025-08-22 19:22","pubTimestamp":1755861749,"startTime":"0","endTime":"0","summary":"Lineage (LINE) has an average rating of hold and mean price target of $50.67, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LINE"],"gpt_icon":0},{"id":"2561122412","title":"Lineage price target lowered to $53 from $60 at Truist","url":"https://stock-news.laohu8.com/highlight/detail?id=2561122412","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561122412?lang=en_us&edition=fundamental","pubTime":"2025-08-22 07:10","pubTimestamp":1755817810,"startTime":"0","endTime":"0","summary":"Truist analyst Ki Bin Kim lowered the firm’s price target on Lineage (LINE) to $53 from $60 and keeps a Buy rating on the shares. The firm decrease...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lineage-price-target-lowered-to-53-from-60-at-truist-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lineage-price-target-lowered-to-53-from-60-at-truist-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LINE"],"gpt_icon":0},{"id":"2561411484","title":"BRIEF-Lineage, Port of New Orleans Collaborate To Expand Bonded Warehouse Space","url":"https://stock-news.laohu8.com/highlight/detail?id=2561411484","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561411484?lang=en_us&edition=fundamental","pubTime":"2025-08-22 05:58","pubTimestamp":1755813518,"startTime":"0","endTime":"0","summary":"BRIEF-Lineage, Port of New Orleans Collaborate To Expand Bonded Warehouse SpaceAug 21 (Reuters) - Lineage Inc LINE.O:LINEAGE AND PORT OF NEW ORLEANS COLLABORATE TO EXPAND BONDED WAREHOUSE SPACE, STREN","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250821:nTUA5FMW30:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LINE","BK4224"],"gpt_icon":0},{"id":"2561419660","title":"Lineage Inc. Expands Global Trade Capabilities with New Customs Bonded Warehouse in New Orleans","url":"https://stock-news.laohu8.com/highlight/detail?id=2561419660","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561419660?lang=en_us&edition=fundamental","pubTime":"2025-08-22 05:00","pubTimestamp":1755810018,"startTime":"0","endTime":"0","summary":"Lineage Inc., the world's largest global temperature-controlled warehouse REIT, has announced the certification of its Jourdan Road facility in New Orleans East as a Class 3 Public Bonded Warehouse. This marks Lineage's first customs bonded facility in Louisiana and enhances the Port of New Orleans'  status as a premier Gulf gateway for global trade. The facility, strategically located on the Inner Harbor Navigation Canal, spans over 304,000 square feet and offers both I-House capabilities and customs bonded storage. This dual designation facilitates efficient importation of temperature-sensitive goods, bolstering the global cold chain and ensuring timely access to perishable products for American consumers.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investmen","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250821:nNDL4yS6tk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LINE","BK4224"],"gpt_icon":0},{"id":"2561419680","title":"Lineage and Port of New Orleans Collaborate to Expand Bonded Warehouse Space, Strengthening Global Trade Flows","url":"https://stock-news.laohu8.com/highlight/detail?id=2561419680","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561419680?lang=en_us&edition=fundamental","pubTime":"2025-08-22 05:00","pubTimestamp":1755810000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250821:nTUA5FMW30:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4224","LINE"],"gpt_icon":0},{"id":"2561467554","title":"Evercore ISI Remains a Hold on Lineage, Inc. (LINE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2561467554","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561467554?lang=en_us&edition=fundamental","pubTime":"2025-08-21 19:57","pubTimestamp":1755777433,"startTime":"0","endTime":"0","summary":"Evercore ISI analyst Steve Sakwa maintained a Hold rating on Lineage, Inc. yesterday and set a price target of $50.00. The company’s shares closed ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/evercore-isi-remains-a-hold-on-lineage-inc-line-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/evercore-isi-remains-a-hold-on-lineage-inc-line-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4224","LINE"],"gpt_icon":0},{"id":"2561484171","title":"Kevin Patrick Marchetti, Co-Executive Chairman, Reports Acquisition of Lineage Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2561484171","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561484171?lang=en_us&edition=fundamental","pubTime":"2025-08-21 05:08","pubTimestamp":1755724108,"startTime":"0","endTime":"0","summary":"Kevin Patrick Marchetti, Co-Executive Chairman of Lineage Inc., reported an acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lineage Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 20, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250820:nNDL1L6M4j:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LINE","BK4224"],"gpt_icon":0},{"id":"2560010976","title":"Capybobo debuts at WebX 2025, unveiling Web3-native Collectible NFT Apparel IP.","url":"https://stock-news.laohu8.com/highlight/detail?id=2560010976","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560010976?lang=en_us&edition=fundamental","pubTime":"2025-08-20 21:10","pubTimestamp":1755695400,"startTime":"0","endTime":"0","summary":"BlockBeats News, August 20th, on the 25th to 26th of this month, Catizen's Web3 game Capybobo will make its appearance at the main venue of WebX 2025 in Tokyo, delivering a keynote speech focusing on ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//en/flash/308281","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_live","symbols":["LU2463526074.USD","LINE","BK4224","BK4136","LU1169590202.USD","LU1481599808.USD","LU1481600234.SGD","BK4585","BK4588","IE00B3T34201.USD","IP","LU1169589451.USD","LU1487256676.USD","BK4144","NEXT"],"gpt_icon":0},{"id":"2560189793","title":"Lineage Is Maintained at Outperform by RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2560189793","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560189793?lang=en_us&edition=fundamental","pubTime":"2025-08-18 23:34","pubTimestamp":1755531240,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LINE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  August 18, 2025 11:34 ET (15:34 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LINE"],"gpt_icon":0},{"id":"2560790924","title":"RBC Cuts Price Target on Lineage to $51 From $64, Keeps Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2560790924","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560790924?lang=en_us&edition=fundamental","pubTime":"2025-08-18 18:57","pubTimestamp":1755514635,"startTime":"0","endTime":"0","summary":"Lineage (LINE) has an average rating of hold and mean price target of $51.06, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LINE"],"gpt_icon":0},{"id":"2560901380","title":"RBC Capital Sticks to Its Buy Rating for Lineage, Inc. (LINE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2560901380","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560901380?lang=en_us&edition=fundamental","pubTime":"2025-08-18 18:56","pubTimestamp":1755514573,"startTime":"0","endTime":"0","summary":"In a report released on August 15, Michael Carroll from RBC Capital maintained a Buy rating on Lineage, Inc., with a price target of $51.00. The co...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/rbc-capital-sticks-to-its-buy-rating-for-lineage-inc-line-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/rbc-capital-sticks-to-its-buy-rating-for-lineage-inc-line-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LINE"],"gpt_icon":0},{"id":"2559966492","title":"Promising Developments and Strong Financial Position Support Buy Rating for Lineage Cell Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2559966492","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559966492?lang=en_us&edition=fundamental","pubTime":"2025-08-15 01:55","pubTimestamp":1755194127,"startTime":"0","endTime":"0","summary":"Analyst Michael Okunewitch from Maxim Group maintained a Buy rating on Lineage Therap and keeping the price target at $3.00. Michael Okunewitch’s r...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/promising-developments-and-strong-financial-position-support-buy-rating-for-lineage-cell-therapeutics-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/promising-developments-and-strong-financial-position-support-buy-rating-for-lineage-cell-therapeutics-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","LINE"],"gpt_icon":0},{"id":"2559267957","title":"Lineage Cell Therapeutics Reports Q2 2025 Progress and Challenges","url":"https://stock-news.laohu8.com/highlight/detail?id=2559267957","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559267957?lang=en_us&edition=fundamental","pubTime":"2025-08-13 12:31","pubTimestamp":1755059483,"startTime":"0","endTime":"0","summary":"Lineage Cell Therapeutics, Inc. ( ($LCTX) ) has released its Q2 earnings. Here is a breakdown of the information Lineage Cell Therapeutics, Inc. pr...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lineage-cell-therapeutics-reports-q2-2025-progress-and-challenges?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lineage-cell-therapeutics-reports-q2-2025-progress-and-challenges?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4224","BK4539","LU2065732104.USD","BK4007","LENZ","LINE","PRGS","BK4097","BK4139"],"gpt_icon":0},{"id":"2559675504","title":"Lineage Cell Revenue Doubles in Q2","url":"https://stock-news.laohu8.com/highlight/detail?id=2559675504","media":"Motley Fool","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559675504?lang=en_us&edition=fundamental","pubTime":"2025-08-13 09:54","pubTimestamp":1755050040,"startTime":"0","endTime":"0","summary":"GAAP revenue doubled in Q2 2025 compared to Q2 2024, significantly beating analyst expectations on a GAAP basis as Collaboration income  also doubled compared to Q2 2024.Net loss  increased sharply due to large non-recurring impairment and warrant revaluation charges, overshadowing otherwise stable operating expenses.Cash and investments  totaled $42.3 million as of June 30, 2025, supporting planned operations through Q1 2027.","market":"us","thumbnail":"https://g.foolcdn.com/image/?url=https%3A%2F%2Fcdn.content.foolcdn.com%2Fimages%2F1umn9qeh%2Fproduction%2F2e67fde4d458002cf59f26acf09dd58f97b62ce0-1024x1024.png&op=resize&w=165&h=104","type":0,"news_type":0,"thumbnails":["https://g.foolcdn.com/image/?url=https%3A%2F%2Fcdn.content.foolcdn.com%2Fimages%2F1umn9qeh%2Fproduction%2F2e67fde4d458002cf59f26acf09dd58f97b62ce0-1024x1024.png&op=resize&w=165&h=104"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/data-news/2025/08/13/lineage-cell-revenue-doubles-in-q2/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["LINE"],"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":1,"totalSize":180,"code":"91000000","status":"200"}]}}